Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

News Release

 View printer-friendly version

Charles River Laboratories to Present at Jefferies Life Sciences Conference

WILMINGTON, Mass.--(BUSINESS WIRE)--June 26, 2006--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that Executive Vice President and Chief Financial Officer Thomas F. Ackerman will present at the Jefferies Life Sciences Conference in New York, on Tuesday, June 27th, at 9:00 a.m. ET. Mr. Ackerman will present an overview of Charles River's business and strategic focus.

A live webcast of the presentation will be available through a link that will be posted on the Investor Relations section of the Charles River Laboratories website, http://ir.criver.com. A webcast replay will be accessible through the same website approximately three hours after the presentation and will remain available through July 11, 2006.

CONTACT: Charles River Laboratories International, Inc.
Investor Relations:
Susan E. Hardy, 781-262-7616
Corporate Vice President, Investor Relations

SOURCE: Charles River Laboratories International, Inc.

Featured Report

2018 Annual Report (PDF)

Investor Hotline

877-567-6CRL (6275)